[1-(dimethylsulfamoyl)-3-ethylpyrazol-4-yl]boronic acid结构式
|
常用名 | [1-(dimethylsulfamoyl)-3-ethylpyrazol-4-yl]boronic acid | 英文名 | [1-(dimethylsulfamoyl)-3-ethylpyrazol-4-yl]boronic acid |
---|---|---|---|---|
CAS号 | 917925-63-4 | 分子量 | 247.08000 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C7H14BN3O4S | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | [1-(dimethylsulfamoyl)-3-ethylpyrazol-4-yl]boronic acid |
---|---|
英文别名 | 更多 |
分子式 | C7H14BN3O4S |
---|---|
分子量 | 247.08000 |
精确质量 | 247.08000 |
PSA | 104.04000 |
~58% [1-(dimethylsul... 917925-63-4 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 191-192 ; WO 2006/136830 A1 |
Boronic acid,B-[1-[(dimethylamino)sulfonyl]-3-ethyl-1H-pyrazol-4-yl] |